Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
about
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.Low-Density Lipoprotein Receptor Deficiency Attenuates Neuroinflammation through the Induction of Apolipoprotein E.Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients.Cardiovascular profile improvement during Natalizumab treatment.A carcinogenic trigger to study the function of tumor suppressor genes in Schmidtea mediterranea.Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.
P2860
Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@en
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@nl
type
label
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@en
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@nl
prefLabel
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@en
Relapsing-remitting multiple s ...... rofile with dysfunctional HDL.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Relapsing-remitting multiple s ...... profile with dysfunctional HDL
@en
P2093
Alan T Remaley
Bart Vanwijmeersch
Denis Sviridov
Elien Wouters
Jeroen F Bogie
Monique T Mulder
Niels Hellings
Roland Valcke
Veerle Somers
Winde Jorissen
P2860
P2888
P356
10.1038/SREP43410
P407
P577
2017-02-23T00:00:00Z